David Efraim Rosen, 10% Owner at HERON THERAPEUTICS, INC. /DE/ (HRTX), bought 4,774,450 shares at $1.50 ($7.2M) on 2025-08-08, disclosed to the SEC on 2025-08-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.50 | 2,387,225 | $3.6M | 50.0% |
| 2 | $1.50 | 2,387,225 | $3.6M | 50.0% |
| Total | $1.50 avg | 4,774,450 | $7.2M | 100% |
| Filing → |
| TXMD | BUY | 2022-08-01 | $2.7M | — | Filing → |
| TXMD | BUY | 2022-07-19 | $935K | — | Filing → |
| RDUS | BUY | 2021-12-15 | $6.4M | — | Filing → |